Perioperative management of patients undergoing cytoreductive surgery combined with heated intraperitoneal chemotherapy for peritoneal surface malignancy: A multi-institutional experience

Annals of Surgical Oncology

Volumn 19, Issue 13, 2012, Pages 4244-4251

  Bell, John C ^a   Rylah, Barnaby G ^a   Chambers, Robert W ^a   Peet, Helen ^a   Mohamed, Faheez ^a   Moran, Brendan J ^a  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; DOPAMINE; FRESH FROZEN PLASMA; FUROSEMIDE; MANNITOL; TRANEXAMIC ACID;

ANESTHESIST; BLOOD CLOTTING DISORDER; CANCER CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; EPIDURAL ABSCESS; FLUID THERAPY; HEALTH SURVEY; HEATED INTRAPERITONEAL CHEMOTHERAPY; HUMAN; NEPHROTOXICITY; ONLINE ANALYSIS; PATIENT CARE; PERIOPERATIVE PERIOD; PERITONEAL SURFACE MALIGNANCY; PERITONEUM CANCER; PEROPERATIVE CARE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE CARE; PREOPERATIVE CARE; REVIEW; SWEDEN; WORKSHOP;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; DISEASE MANAGEMENT; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; PROGNOSIS;

EID: 84876494525     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2496-y     Document Type: Review

References (50)

1. Moran B, Baratti D, Yan TD, Kusamura S, Deraco M. Consensus statement on the loco-regional treatment of appendiceal mucin-ous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol. 2008;98:277-82.
2. BeVan KE, Mohamed F, Moran BJ. Pseudomyxoma peritonei. World J Gastrointest Oncol. 2010;2:44-50.
3. Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, AlexanDer R, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann Surg Oncol. 2007;14:128-33. (Pubitemid 44954279)
4. Deraco M, Baratti D, Laterza B, Balestra MR, Mingrone E, Macri A, et al. Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer. Eur J Surg Oncol. 2011;37:4-9.
5. Mohamed F, Moran BJ. Morbidity and mortality with cytore-ductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J. 2009;15:196-9.
6. Moran BJ. Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf). 2006;28:375-8. (Pubitemid 44863329)
7. Smeenk RM, Verwaal VJ, ZoetmulDer FA. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94:1408-14. (Pubitemid 350144391)
8. Yan TD, Links M, Fransi S, Jacques T, Black D, Saunders V, et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol. 2007;14:2270-80. (Pubitemid 47174916)
9. Bartlett DL. HIPEC: the complexities of clinical trials. Ann Surg Oncol. 2008;15:1277-9.
10. Behera M, Kumar A, Soares HP, Sokol L, Djulbegovic B. Evidence-based medicine for rare diseases: implications for data interpretation and clinical trial design. Cancer Control. 2007; 14:160-6. (Pubitemid 46515152)
11. Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg. 1995;130:423-9.
12. Raue W, Tsilimparis N, Bloch A. Volume therapy and cardiocir-cular function during hyperthermic intraperitoneal chemotherapy. Eur Surg Res. 2009;43:365-72.
13. Yan T, Black D, Savady R, Sugarbaker P. A systematic review on the efficacy of cytoreductive surgery and perioperative intra-peritoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2006;14:484-92.
14. Kumar A, Anel R, Bunnell E. Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med. 2004;32:691-9. (Pubitemid 38340065)
15. Marik PE, Baram M, Vahid Bl. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134:172-8.
16. Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens, a randomized assessor-blinded multicenter trial. Ann Surg. 2003;238:641-8. (Pubitemid 38182252)
17. Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, Matot I. Effect of intraoperative fluid management on outcome after intraabdominal surgery. Anesthesiology. 2005;103:25-32. (Pubitemid 40943133)
18. Grocott M, Mythen M, Gan T. Perioperative fluid management and clinical outcomes in adults. Anesth Analg. 2005;100:1093-106. (Pubitemid 40404217)
19. Wakeling HG, McFall MR, Jenkins CS, Woods WG, Miles WF, Barclay GR, et al. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005;95:634-42. (Pubitemid 41600025)
20. Giglio M, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth. 2009;103:637-46.
21. Tote S, Grounds R. Performing perioperative optimization of the high risk surgical patient. Br J Anaesth. 2006;97:4-11.
22. Venn R, Steele A, Richardson P, Poloniecki J, Grounds M, Newman P. Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures. Br J Anaesth. 2002;88:65-71. (Pubitemid 34048564)
23. Powell-Tuck J, Gosling P, Lobo DN, Allison SP, Carlson GL, Gore, M, et al. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients GIFTASUP 2010.
24. Jonas M, Fennell J, Brudney CS. Haemodynamic optimisation of the surgical patient revisited. Anaesthesia Int. 2008;2.
25. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pa-gliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:410-7.
26. Schmidt C, Creutzenberg M, Piso P, Hobbhahn J. Bucher M. Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Anaesthesia. 2008;63:389-95. (Pubitemid 351365036)
27. Boldt J. Use of albumin: an update. Br J Anaesth. 2010;104: 276-84.
28. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350: 2247-56.
29. Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: A prospective, randomized, controlled, pilot study. Crit Care Med. 2006;34: 2536-40. (Pubitemid 44413049)
30. Yuan XY, Zhang CH, He YL, Yuan YX, Cai SR, Luo NX, et al. Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery? A prospective randomized controlled trial. Am J Surg. 2008;196:751-5.
31. Schmidt C, Moritz S, Rath S, Grossmann E, Wiesenack C, Piso P, et al. Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis. J Surg Oncol. 2009;100: 297-301.
32. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64:1211-7. (Pubitemid 351671214)
33. Dedrick RL. Theoretical and experimental bases of intraperito-neal chemotherapy. Semin Oncol. 1985;12:1-6. (Pubitemid 16222022)
34. Gilly FN, Carry PY, Sayag AC, Brachet A, Panteix G, Salle B, et al. Regional chemotherapy (with mitomycin C) and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology. 1994;41:124-9. (Pubitemid 24140784)
35. Glehen O, Beaujard AC, Arvieux C, Huber O, Gilly FN. Peritoneal carcinomatosis. Surgical treatment, peritonectomy and intraperitoneal chemohyperthermia. Gastroenterol Clin Biol. 2002;26:210-5. (Pubitemid 34408007)
36. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcino-matosis and sarcomatosis. Semin Surg Oncol. 1998;14:254-61. (Pubitemid 28146518)
37. Esquivel J, Angulo F, Bland RK, Stephens AD, Sugarbaker PH. Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open ''coliseum technique''. Ann Surg Oncol. 2000;7:296-300. (Pubitemid 30318318)
38. Cafiero T, Di Iorio C, Di Minno RM, Sivolella G, Confuorto G. Non-invasive cardiac monitoring by aortic blood flow determination in patients undergoing hyperthermic intraperitoneal intraoperative chemotherapy. Minerva Anestesiol. 2006;72: 207-15.
39. Celeen W, Peeters M, Houtmeyers C, Breusegem C, De Somer F, Pattyn P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high dose oxaliplatin in patients with peritoneal carcinomatosis. Ann Surg Oncol. 15;2:535-41.
40. Nair RL, Tobias J, Stemmerman G, Lowy AM. Cerebral edema in a patient following cytoreductive and hyperthermic intraoperative intraperitoneal chemoperfusion. World J Surg Oncol. 2006;4:85.
41. Raft J, Parisot M, Marchal F, Tala S, Desandes E, Lalot JM, et al. Impact of the hyperthermic intraperitoneal chemotherapy on the fluid-electrolyte changes and on the acid-base balance. Anna Fr Anesth Reanim. 2010;29:676-81.
42. Verwaal VJ, Van Tinteren H, Van Ruth SV, ZoetmulDer FA. Toxicity of cytoreductive surgery and hyperthermic intra-perito-neal chemotherapy. J Surg Oncol. 2004;85:61-7. (Pubitemid 38160772)
43. Desgranges F-P, Steghens A, Mithieux F, Rosay H. Potential risks of thoracic epidural analgesia in hyperthermic intraperito-neal chemotherapy. J Surg Oncol. 2010;101:442.
44. Schmidt C, Steinke T, Moritz S, Bucher M. Thoracic epidural anesthesia in patients with cytoreductive surgery and HIPEC. J Surg Oncol. 2010;102:545-6.
45. Cook TM, Counsell D, Wildsmith JA; Royal College of Anaesthetists Third National Audit Project. Major complications of central neuraxial block: report on the Third National Audit Project of the Royal College of Anaesthetists. Br J Anaesth. 2009;102:179-90.
46. Murphy EM, Sexton R, Moran BJ. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum. 2007;50:37-42. (Pubitemid 46147019)
47. European Community Directive 2000/34/EC of the European Parliament and of the Council. OJEC. 2000;L195:41.
48. Bartel P, Offermeier W, Smith F, Becker P. Attention and working memory in resident anaesthetists after night duty: group and individual effects. Occup Environ Med. 2004;612:167-70. (Pubitemid 38141975)
49. Williamson AM, Feyer AM. Moderate sleep deprivation produces impairments in cognitive and motor performance equivalent to legally prescribed levels of alcohol intoxication. Occup Environ Med. 2000;57:649-55.
50. Youssef H, Newman C, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Operative findings, early complications, and longterm survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum. 2011;54:293-9.